Given the promising, albeit conflicting, data about PITX2 methylation and risk of disease progression in cancer, the methylation status of PITX2 and PANCR and its potential function as a prognostic biomarker was investigated in a well annotated HNSCC cohort. Here, PANCR is linked to cancer.